UPClytics
EnglishDeutsch
Sign inSign up
View all cases

UPC APP 10151/2025

Feb 27, 2025·EP2501384: METHOD OF TREATING PROLIFERATIVE DISORDERS AND OTHER PATHOLOGICAL CONDITIONS MEDIATED BY BCR-ABL, C-KIT, DDR1, DDR2 OR PDGF-R KINASE ACTIVITY

Case details
Status
Case Closed
Action
Generic
Category
Document Access (RoP262)
Parties
Claimants
Reps: Phillip Rektorschek
Division
Milan CD
Judges
Technology
Organic Chemistry
Language
English
First decided
Apr 10, 2025
Decisions
  • 2025-04-10
    Application RoP262.1 (b)

    The Milan Central Division granted ALIUD PHARMA's application for access to pleadings filed in closed proceedings between Accord Healthcare and Novartis (EP 2 501 384) under R. 262.1(b) RoP, after Novartis withdrew its objection following settlement of the main proceedings.

    Legal issues:R. 262.1(b) public access to fileAccess to pleadings after case closureRedaction of personal data
Documents
Document titleDatePublic
Headnote-and-Keywords2025-04-10Not public
Outcome of the Order2025-04-10Not public
ORDER2025-04-10Public
Template-Order2025-04-10Not public
Comments2025-04-03Not public
Comments2025-04-03Not public
25-03-27_-_Statement_re_request_pursuant_R._262_(1)b_RoP2025-03-27Not public
Annex FS202025-03-27Not public
Annex FS202025-03-27Not public
ORDER 12 MARCH 20252025-03-12Not public
Exhibit A 032025-02-27Not public
Exhibit A 022025-02-27Not public
Application2025-02-27Not public
Exhibit A 012025-02-27Not public